home / stock / agtc / agtc news

AGTC News and Press, Applied Genetic Technologies Corporation From 09/02/20

Stock Information
Company Name: Applied Genetic Technologies Corporation
Stock Symbol: AGTC
Market: NASDAQ
Website: agtc.com
Menu
AGTC AGTC Quote AGTC Short AGTC News AGTC Articles AGTC Message Board
Get AGTC Alerts

News, Short Squeeze, Breakout and More Instantly...
AGTC - AGTC to Host Management Update on September 9 at 8:00 am ET to Discuss Planned Phase 2/3 XLRP Trial, Share Additional XLRP Data and Report Fourth Quarter and Fiscal Year End 2020 Financial Results

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...
AGTC - AGTC Announces Publication of Preclinical Data that Support the Ongoing Clinical Development of Its XLRP Gene Therapy Program

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...

AGTC - Applied Genetic Technologies (AGTC) Presents At Wedbush Pacgrow Healthcare Virtual Conference - Slideshow

The following slide deck was published by Applied Genetic Technologies Corporation in conjunction with this Read more ...

AGTC - AGTC Formalizes Patient Advisory Council to Provide Insights and Guidance on Patient Perspectives for Pipeline Therapies

Patient Advisory Council to include advocates from the inherited retinal diseases global community  New Patient Advisory Council to focus initially on Company ’ s clinical stage programs for X-linked retinitis pigmentosa (XLRP) GAINESVILLE, Fla., and CAMBRIDGE, Mass....
AGTC - AGTC to Present at the Wedbush PacGrow Virtual Healthcare Conference on August 11, 2020

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announce...

AGTC - Applied Genetic Tech to expand study of gene therapy for vision loss disorder

Based on FDA feedback, Applied Genetic Technologies (NASDAQ: AGTC ) has revised the development plan for its gene therapy for X-linked retinitis pigmentosa , an inherited disorder affecting the retina that leads to vision loss. More news on: Applied Genetic Technologies Corporation, H...

AGTC - AGTC Announces Updated Development Plan for its X-Linked Retinitis Pigmentosa Clinical Program, Including Q1 2021 Start of Planned Phase 2/3 Trial

FDA feedback allows for forward program development Company reiterates that its favorable safety profile and its advanced manufacturing and analytics capabilities enable rapid clinical development GAINESVILLE, Fla. and CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) -- Applied Gen...
AGTC - AGTC Set to Join Russell 3000® and 2000® Indexes

GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 24, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...

AGTC - AGTC Announces Significant Productivity and Quality Enhancement To Its Proprietary Manufacturing Process

Upgraded Manufacturing Process Being Used For Production Of Pivotal Stage Clinical Trial Materials GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trial...

AGTC - AGTC to Present at BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference on June 23, 2020

GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 16, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...
Previous 10 Next 10